CLINICAL_TRIALS
research
· 2026-04-22
Clinical Trial Update: Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD) [NA]
Summary
This document describes the HEARTWISE-ASCVD clinical trial, a study evaluating health-enhanced artery risk tracking with wide implementation and ASCVD screening…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Artery Calcification | NA | Status: NOT_YET_RECRUITING